These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36128341)

  • 1. Providing peer navigation services to women with a history of opioid misuse pre- and post-release from jail: A program description.
    Tillson M; Fallin-Bennett A; Staton M
    J Clin Transl Sci; 2022; 6(1):e106. PubMed ID: 36128341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women.
    Staton M; Webster JM; Leukefeld C; Tillson M; Marks K; Oser C; Bush HM; Fanucchi L; Fallin-Bennett A; Garner BR; McCollister K; Johnson S; Winston E
    J Subst Abuse Treat; 2021 Sep; 128():108284. PubMed ID: 33455828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.
    Howell BA; Puglisi L; Clark K; Albizu-Garcia C; Ashkin E; Booth T; Brinkley-Rubinstein L; Fiellin DA; Fox AD; Maurer KF; Lin HJ; McCollister K; Murphy S; Morse DS; Shavit S; Wang K; Winkelman T; Wang EA
    J Subst Abuse Treat; 2021 Sep; 128():108315. PubMed ID: 33583610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
    Evans EA; Stopka TJ; Pivovarova E; Murphy SM; Taxman FS; Ferguson WJ; Bernson D; Santelices C; McCollister KE; Hoskinson R; Lincoln T; Friedmann PD;
    J Subst Abuse Treat; 2021 Sep; 128():108275. PubMed ID: 33483222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study.
    Cheng A; Badolato R; Segoshi A; McDonald R; Malone M; Vasudevan K; Badiei B; Sugarman A; Macdonald R; Mangat J; Giftos J; Lee JD; Tofighi B
    Addict Sci Clin Pract; 2022 Jan; 17(1):4. PubMed ID: 35093164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.
    Rinehart DJ; Stowell M; Collings A; Durfee MJ; Thomas-Gale T; Jones HE; Binswanger I
    J Subst Abuse Treat; 2021 Jul; 126():108318. PubMed ID: 34116817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility Study.
    Banta-Green CJ; Floyd AS; Vick K; Arthur J; Hoeft TJ; Tsui JI
    Subst Abuse Rehabil; 2019; 10():57-67. PubMed ID: 31695555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and Acceptability of a Digital Health Intervention to Promote Continued Engagement in Medication for Opioid Use Disorder Following Release From Jail/Prison.
    Langdon KJ; Jiménez Muñoz P; Block A; Scherzer C; Ramsey S
    Subst Abuse; 2022; 16():11782218221127111. PubMed ID: 36188441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.
    Scott CK; Grella CE; Dennis ML; Carnevale J; LaVallee R
    Health Justice; 2022 Dec; 10(1):36. PubMed ID: 36538121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Project ECHO to promote evidence based care for justice involved adults with opioid use disorder.
    Adams ZW; Agley J; Pederson CA; Bell LA; Aalsma MC; Jackson T; Grant MT; Ott CA; Hulvershorn LA
    Subst Abus; 2022; 43(1):336-343. PubMed ID: 34283701
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives among women receiving medications for opioid use disorder: Implications for development of a peer navigation intervention to improve access to family planning services.
    Stowell MA; Thomas-Gale T; Jones HE; Binswanger I; Rinehart DJ
    Subst Abus; 2022; 43(1):722-732. PubMed ID: 35100081
    [No Abstract]   [Full Text] [Related]  

  • 13. Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.
    King Z; Kramer C; Latkin C; Sufrin C
    J Subst Abuse Treat; 2021 Jul; 126():108338. PubMed ID: 34116823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study.
    Saunders EC; Satcher MF; Monico LB; McDonald RD; Springer SA; Farabee D; Gryczynski J; Nyaku A; Reeves D; Kunkel LE; Schultheis AM; Schwartz RP; Lee JD; Marsch LA; Waddell EN
    Health Justice; 2022 Dec; 10(1):35. PubMed ID: 36529829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile-Enhanced Prevention Support Study for Men Who Have Sex With Men and Transgender Women Leaving Jail: Protocol for a Randomized Controlled Trial.
    Edwards GG; Reback CJ; Cunningham WE; Hilliard CL; McWells C; Mukherjee S; Weiss RE; Harawa NT
    JMIR Res Protoc; 2020 Sep; 9(9):e18106. PubMed ID: 32959786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing Peer Recovery Support Services to Address the Central Appalachian Opioid Epidemic: The West Virginia Peers Enhancing Education, Recovery, and Survival (WV PEERS) Pilot Program.
    Davis SM; Stover AN; Linn H; Dower J; McCawley D; Winstanley EL; Feinberg J
    J Appalach Health; 2021; 3(3):36-50. PubMed ID: 35770037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials.
    Murphy SM; Jeng PJ; Poole SA; Jalali A; Vocci FJ; Gordon MS; Woody GE; Polsky D
    Addict Sci Clin Pract; 2020 Apr; 15(1):15. PubMed ID: 32321570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoping review of interventions to link individuals to substance use services at discharge from jail.
    Grella CE; Ostlie E; Watson DP; Scott CK; Carnevale J; Dennis ML
    J Subst Abuse Treat; 2022 Jul; 138():108718. PubMed ID: 35012792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtually possible: using telehealth to bring reproductive health care to women with opioid use disorder in rural Maine.
    Thompson TA; Ahrens KA; Coplon L
    Mhealth; 2020; 6():41. PubMed ID: 33437837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.
    Anvari MS; Kleinman MB; Massey EC; Bradley VD; Felton JW; Belcher AM; Magidson JF
    J Subst Abuse Treat; 2022 Jul; 138():108721. PubMed ID: 35067397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.